Bio Asia 2024 driving entrepreneurship in life sciences

Hyderabad: BioAsia 2024, recognized as one of the foremost gatherings in the life-sciences and healthcare sectors across Asia, is poised to be a catalyst for innovation and entrepreneurship, with a heightened emphasis on showcasing startups. Organized under the auspices of the State government of Telangana, BioAsia is committed to reshaping the landscape for emerging businesses within the healthcare and life sciences domains.

The 'Innovation Zone' at BioAsia 2024 will emerge as a vibrant hub, housing both the Startup Stage Pavilion and the Incubator Pavilion, fostering an environment conducive to innovation and facilitating investment opportunities. This segment of the event will serve as a melting pot of ideas, bringing together startups, investors, and industry experts to explore collaborative opportunities and drive transformative change.

A select group of approximately 70 startups have secured coveted spots in the 21st edition of BioAsia, earning the opportunity to showcase their innovative solutions on a global stage. These startups, spanning various facets of healthcare and life sciences, will benefit from waived participation fees and complimentary display booths, providing them with a platform to gain visibility and attract potential partners and investors.

In addition to the exposure offered through the exhibition, selected startups will have the exclusive privilege of engaging in one-on-one interactions with esteemed industry leaders and visionaries. The presence of influential figures such as Mr. David Ricks, CEO of Eli Lilly, and Mr. Chris Boerner, CEO of Bristol Myers Squibb, among others, will offer startups invaluable insights and networking opportunities, further amplifying their growth prospects.

Sridhar Babu, Minister for Industries & Commerce Dept., Govt of Telangana, expressed his enthusiasm for the event's growing global stature. He stated, "BioAsia has emerged as a critical instrument for the development of the Indian and global Life-Sciences and allied industries over the last two decades. We are thrilled to announce that several global CEOs will be attending BioAsia for the first time, underlining the event's rising prominence on the international stage. My team and I are leaving no stone unturned to ensure that BioAsia 2024 is grand and impactful. It's not just an event; it's a culmination of two decades of excellence. Together, let's shape the future of healthcare."

The annual BioAsia conference, scheduled to be held from February 26 to 28, 2024, at the Hyderabad International Convention Centre (HICC), promises to be a cornerstone event for stakeholders across the healthcare and life sciences spectrum. With its focus on fostering innovation, facilitating partnerships, and driving meaningful conversations, BioAsia 2024 is poised to redefine the future of healthcare innovation in the region and beyond.